Contact sensitivity to quinazoline oxide.
Rudzki
E
E
Department of Dermatology, Warsaw Medical School, Poland.
Rebandel
P
P
D000328:Adult; D000485:Allergens / Q000009:adverse effects*; D017449:Dermatitis, Allergic Contact / Q000175:diagnosis / Q000209:etiology*; D009783:Dermatitis, Occupational / Q000175:diagnosis / Q000209:etiology*; D004345:Drug Industry; D005148:Facial Dermatoses / Q000139:chemically induced* / Q000175:diagnosis; D005260:Female; D006229:Hand Dermatoses / Q000139:chemically induced* / Q000175:diagnosis; D006801:Humans; D016273:Occupational Exposure / Q000009:adverse effects*; D010328:Patch Tests; D011799:Quinazolines / Q000009:adverse effects*
D000485:Allergens; D011799:Quinazolines; C050843:2-chloromethyl-4-phenyl-6-chloroquinazoline-3-oxide